Meridian Energy Ltd (MEZ)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 4.590 |
|---|---|
| 52-week range | 4.200 – 5.290 |
| Return, 1 month / 3 months | +1.3% / −2.3% |
| Return, 1 year / 3 years | −7.5% / +14.4% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 31.0% |
| Worst drawdown (1 year) | -16.6% |
| Average daily value traded | 0.08M AUD |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Meridian Energy is a New Zealand electricity company based in Wellington. It generates power from renewable sources, chiefly hydroelectric stations in the South Island and wind farms, and it retails electricity to households and businesses in New Zealand and Australia. The company also supplies energy to large industrial customers and trades electricity in the wholesale market. Its operations centre on producing and selling power rather than on manufacturing goods.
Meridian Energy Ltd trades under the code MEZ on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Meridian Energy Ltd (MEZ) trades on the Australian Securities Exchange in Australia. It last closed at AUD 4.590 on 23 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 350 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.5% and over the last three months it fell 2.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 1.4% | ||
| From 52-week high | -13.1% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.3% | ||
| 6-month return | 2.8% | ||
| 12-month return, skipping the last month | -8.7% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -16.6% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.08M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +1.3% |
| 3 months | −2.3% |
| 6 months | +2.8% |
| 1 year | −7.5% |
| 3 years | +14.4% |
| 5 years | +12.8% |
Signals
| 50-day / 200-day average | 4.406 / 4.526 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.123 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | NZD 0.1280 |
| 5 Mar 2026 | NZD 0.0515 |
| 4 Sep 2025 | NZD 0.1276 |
| 6 Mar 2025 | NZD 0.0548 |
| 4 Sep 2024 | NZD 0.1325 |
| 8 Mar 2024 | NZD 0.0549 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.